Your Location:Home >Products >Pharmaceutical intermediate >1029044-16-3
Purity:99%
A novel synthetic route to CSF1R inhibit...
A new and general method to functionaliz...
The invention discloses an intermediate ...
The invention relates to the field of ch...
C20H15ClF3N5O3
5-((5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl)-N-((6-(trifluoromethyl)pyridin-3-yl)methyl)pyridin-2-amine
Conditions | Yield |
---|---|
With
5%-palladium/activated carbon; hydrogen; ammonium chloride;
In
methanol;
at 30 - 35 ℃;
for 6h;
under 1500.15 - 2250.23 Torr;
Solvent;
Reagent/catalyst;
Temperature;
Autoclave;
Green chemistry;
|
98.1% |
5-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]pyridin-2-amine
6-(trifluoromethyl)pyridine-3-carbaldehyde
5-((5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl)-N-((6-(trifluoromethyl)pyridin-3-yl)methyl)pyridin-2-amine
Conditions | Yield |
---|---|
With
triethylsilane; trifluoroacetic acid;
In
acetonitrile;
at 15 - 82 ℃;
|
89.4% |
With
triethylsilane; trifluoroacetic acid;
In
acetonitrile;
at 65 ℃;
for 36h;
|
89% |
With
sodium tetrahydroborate; acetic acid;
In
methanol;
|
86% |
tert-butyl N-[(tert-butoxy)carbonyl]-N-(5-formylpyridin-2-yl)carbamate
5-chloro-1H-pyrrolo[2,3-b]pyridine
C23H27ClN4O5
6-(trifluoromethyl)pyridine-3-carbaldehyde
CAS:65896-14-2
CAS:2306-27-6
CAS:110661-59-1